1. Home
  2. ABVE vs TLSA Comparison

ABVE vs TLSA Comparison

Compare ABVE & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Above Food Ingredients Inc.

ABVE

Above Food Ingredients Inc.

HOLD

Current Price

$0.91

Market Cap

133.6M

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.32

Market Cap

155.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABVE
TLSA
Founded
2019
2013
Country
Canada
United Kingdom
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.6M
155.2M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
ABVE
TLSA
Price
$0.91
$1.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
111.1K
Earning Date
07-09-2026
05-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$0.73
52 Week High
$6.56
$2.60

Technical Indicators

Market Signals
Indicator
ABVE
TLSA
Relative Strength Index (RSI) 34.22 46.96
Support Level $0.32 $1.28
Resistance Level $2.08 $1.56
Average True Range (ATR) 0.15 0.09
MACD -0.01 -0.00
Stochastic Oscillator 39.24 41.07

Price Performance

Historical Comparison
ABVE
TLSA

About ABVE Above Food Ingredients Inc.

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.

Share on Social Networks: